Accelerated adverse cardiac remodeling in a model of TET2 mutation-driven clonal hematopoiesis is ameliorated by IFNa treatment by modulating the monocyte response
Event: ESC Cardio-Oncology 2025
Topic: Research and New Technology
Session: Understanding the interplay between cancer and cardiovascular disease
